Clinical research during COVID-19

Clinical research during COVID-19
Colin Kerr
Colin Kerr
Published: Wednesday, April 8, 2020
Sathish Srinivasan
Sathish Srinivasan, Associate European Editor of the Journal of Cataract and Refractive Surgery, says that clinical research will have a major impact during the current pandemic. As most ophthalmology units are currently seeing only patients with ocular emergency, clinical research involving prospective patient follow ups will be taking a back seat during this difficult period. Professor Srinivasan said that while research would have a major effect in helping ophthalmologists and other healthcare professionals to contain COVID-19, the major challenge they faced was in adjusting to the day-to-day reality of fighting the virus. “Healthcare professionals, like everyone else, have been thrown into a new world dominated by fear and uncertainty,” he said. “We are wondering what we can do to confront this pandemic. As is the case with my friends and colleagues, this is certainly the first experience of a serious global pandemic. As ophthalmologists, our roles are a bit unclear. In my university practice, we have seen a complete shift of roles and workloads of my medical colleagues. There has been lack of clarity on the use of personal protective equipment in an ophthalmology setting and as per our local guidelines and policies we are trying our best to provide a safe environment for our patients and our staff. Also, the current scenario has a major impact on teaching and training residents,” he said. In conclusion, Dr Srinavasan said that he was optimistic for the future of ophthalmology after COVID-19. “With the decrease in workload and with the enforcement of social distancing I certainly feel this is a good time to collate your results, analyse and finish writing up the manuscripts if one is at that stage,” said Prof Srinavasan, Consultant Ophthalmologist at University Hospital Ayr, Ayrshire, Scotland. Dr Srinavasan, in an interview with EuroTimes, said there had been no notable decrease in submission to JCRS since the outbreak of COVID-19. “We are only two-to-three weeks into ‘lockdown period’, therefore I haven't seen any impact to the submissions,” said Prof Srinavasan. “However, it is worth bearing in mind that there is a time lag between conducting the research, analysing and writing up the manuscripts.  In other words,” he said,” the work on manuscripts that are currently being submitted was done one-to-two years ago, depending on the type of clinical research.” “I have no doubt that collectively as a society, humanity will get past this pandemic, although I feel there will be change in perspective and our lifestyle,” he said.
Tags: covid-19, research
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...